exhibition
register now
get brochure
add event to diary
email this to...
contact us
Contact LIVE

look back at 2008
  • 100+ participants
  • 8 health agency speakers
  • 21 sessions over 3 days
  • 65% industry participation
  • 28 hours total duration
  • 7 hours networking time

    • › Request 2009 brochure
    conference details
    Conference:
    Pre-conference workshop
    8 December 9am - 5pm
    Day 1
    9 December 8am - 5.30pm
    Day 2
    10 December 8am - 5.30pm
    Post-conference workshop
    11 December 9am - 5pm
     
    Venue: Royal Garden Hotel, London, United Kingdom
     
     
    Register online now 
    or call +44 (0) 207 608 7055

     

     

     

    Pre-conference workshop - 8 December 2009

    last modified: 09/12/2009 14:00:09 (GMT)
    Pre-conference workshop - 8 December 2009
    8.55am

    Evaluating patient outcomes for assessing health technologies

    Objectives
    This interactive session will provide attendees with an overview of patient reported outcomes and how they are used, developed and evaluated along with methodological requirements for their use to support licensing and reimbursement applications in the major markets.
    9am

    Registration and coffee

    9.30am

    Capturing patients’ perspective in developing and evaluating new technologies - is there added value?

    • Trends of increasing involvement of patients in health care decisions making
    • Evaluating health technologies- is the patients’ voice being heard?
    • Added value of capturing Patient Reported Outcome (PROs)
    10am

    Methods of capturing patient perspectives of value- 1

    • Disease specific and generic measures of health related quality of life /  patient reported outcomes - with examples from trials and label claims
    • Treatment satisfaction and work productivity
    10.30am

    Morning tea

    11am

    Methods of capturing patient perspectives of value - 2

    • Preference based methods and how they are used to demonstrate value: QALYs, Conjoint Analyses, Dicrete Choice Experiments
    12pm

    Lunch

    1pm

    Regulatory requirements for Patient Reported Outcomes - work groups interactive sessions

    • Regulatory requirements for the development of new patient reported outcome tests, testing and qualitative work required for item development and validation studies
    • Discussion of examples from EMEA and the FDA to identify areas for strategic planning
    • Requirements from HTA and reimbursement agencies – examples from major markets and emerging trends
    2pm

    Afternoon tea

    2.30pm

    Planning the strategy for demonstrating value

    • Generating evidence to demonstrate value from the patients point of view
    • Working through the process of drug development and commercialisation for successful market access- starting with the end in mind
    • Evaluating treatment benefit: demystifying endpoint models - with examples
    • Uncovering heterogeneity to focus in on value
    3.30pm

    Interactive session

    Workshop facilitators will help participants work through hypothetical scenarios to apply the learnings from the workshop.
    next »
    Register Now! »
    last modified: 09/12/2009 14:00:09 (GMT)

    Sponsors
     

     
    our speakers
    Meindert Boysen
    Associate Director Single Technology Appraisals
    NICE
     
    Dr François Meyer
    Director, Health Technology Assessment Division
    Haute Autorité de
    Santé
     
    Dr Allan Korn
    Senior Vice President, Chief Medical Officer
    BlueCross BlueShield Association
     
    Jerome Boehm
    Head EU level activities on HTA
    European Commission
     
    Dr Matthias Perleth
    Head of Methods Department
    Gemeinsamer Bundesausschuss

     

    comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX